News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Prenatal Testing Offers a Window for Finding a Mother’s Cancer Risk

hand with stethoscope on pregnant woman's abdomen

Harmful variants in the BRCA1 gene greatly increase a person’s lifetime risk of developing breast, ovarian and pancreatic cancers, but most people are unaware they are carriers. In a new study in the American Journal of Obstetrics and Gynecology, researchers from Weill Cornell Medicine, Columbia University Irving Medical Center (CUIMC)  and NewYork-Presbyterian explored the possibility of including BRCA1 testing at the time of obstetrical prenatal carrier screening. The researchers found that such an approach is not only cost-effective, it also can identify at-risk people at a time when cancer screening and other preventative strategies could save their lives.

Breast Cancer Precision Care: A Family Affair

A woman smiling

Video of Breast Cancer Precision Care: A Family Affair | Weill Cornell Medicine

When Nila Charles was diagnosed with breast cancer, she was the mother of two young children, working long hours and caring for a family member who was also diagnosed with cancer.

"It was a tough time, but I rallied through it," Charles recalled. "My care team at Weill Cornell Medicine was incredible and helped me so much."

Charles discovered her diagnosis during a routine mammogram and learned that she was BRCA2-positive through a genetic testing program co-led by Dr. Melissa Frey, co-director of the genetics and personalized cancer prevention program in the Meyer Cancer Center and an associate professor of obstetrics and gynecology at Weill Cornell Medicine.

Prestigious NIH Grant Explores Repetitive DNA Sequences and Cell Dysfunction

Dr. Jeannine Gerhardt

Dr. Jeannine Gerhardt, an assistant professor of stem cell biology in obstetrics and gynecology and in reproductive medicine at Weill Cornell Medicine, has received a five-year, $2.1 million grant from the National Institute of General Medical Sciences (NIGMS), part of the National Institutes of Health, for the study of repetitive DNA and RNA sequences and the mechanisms by which they cause cell dysfunction and diseases.

The NIGMS Maximizing Investigators’ Research Award is intended to support recipients’ research more broadly and flexibly than standard project grants, which must specify proposed research thoroughly in advance.

“This award is particularly nice because it gives us the flexibility to follow up on any surprising findings as we pursue our research interests,” said Dr. Gerhardt.

Repetitive DNA sequences, or DNA repeats, are patterns of nucleotides, the building blocks of DNA, that occur in multiple copies (such as CAGCAGCAGCAG...). Some are found only in a specific gene, whereas others occur at multiple sites across the genome. While DNA repeats are common, and most are not harmful, others clearly cause diseases.